STUB1 and coronary artery disorder: After leukemic transformation, ischemic cardiovascular disease (iCVD) is the pathology with higher risk in CHIP carriers, with an estimated 2‐fold increased risk of coronary heart disease and a 4‐fold increased risk of myocardial infarction in CHIP carriers compared to non‐carriers, with the strongest associations observed for TET2‐ and JAK2‐mutant cases.